PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-02-19 (1)

Date Title Company
19-Feb-2023 Takeda Presents Positive Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal Acute Graft-Versus-Host Disease (aGvHD) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Businesswire